PaciBioMed-B (02565.HK) appoints Liao Yilin as an independent non-executive director.

China Fortune Finance App News, Pagani Biopharmaceuticals-B (02565.HK) announced that Ms. Liao Yilin has been appointed as an independent non-executive director of the second board of directors, with a term from June 24, 2026 until the end of the term of the second board of directors. Ms. Liao Yilin will serve as the chairman of the audit committee and as a member of the compensation and assessment committee and the nomination committee, with a term consistent with her appointment as an independent non-executive director of the second board of directors.